About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Nashville | 10,809 Studies Near You

Clinical TrialsNashville

Clinical Trials in Nashville

Discover 10,809 clinical trials near Nashville, Tennessee. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1921-1940 of 10,809 trials

Approved for marketingLong Term Treatment With L-DOPSThis study is designed to supply L-DOPS (droxidopa) on a long term basis to patients with a genetic form of profound orthostatic hypotension, most commonly DBH deficiency.NCT00889135·Nashville, Tennessee CompletedEvaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)Primary Objective: \- To demonstrate that lixisenatide can reduce cardiovascular (CV) morbidity and mortality (composite endpoint of CV death, non-fatal myocardial infarction…NCT01147250·Birmingham, Alabama and 828 others

Find Trials by Condition in Nashville

Breast Cancerin Nashville Lung Cancerin Nashville Prostate Cancerin Nashville Colorectal Cancerin Nashville Melanomain Nashville Leukemiain Nashville Lymphomain Nashville Pancreatic Cancerin Nashville Ovarian Cancerin Nashville Brain Cancerin Nashville

Data from ClinicalTrials.govTerms

CompletedSafety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of AgeStudy of the safety and immunogenicity of 20vPnC and influenza vaccine administered at the same visit or separatelyNCT04526574·Mobile, Alabama and 62 others

CompletedResearch Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye DiseaseSURF-200 is being studied in people experiencing an episodic flare-up of their dry eye disease.NCT04734210·Dothan, Alabama and 27 others

TerminatedInvestigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung CarcinomaGSK2879552 is a potent, selective, mechanism-based inactivator of Lysine Specific Demethylase 1 (LSD1)/ CoRepressor for Element-1-Silencing Transcription factor (CoREST) activity.NCT02034123·St Louis, Missouri and 7 others

TerminatedCetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryThis phase 0 trial is studying whether 2 weeks of cetuximab and dasatinib will change tumor cells in patients with colorectal cancer and liver metastases that can be removed by…NCT00835679·Tampa, Florida and 1 other

Active not recruitingAbbott Atrial Fibrillation Post Approval StudyThis post-approval study is designed to provide continued real-world clinical evidence to confirm the safety and long-term effectiveness of atrial fibrillation (AF) radiofrequency…NCT05434650·Huntsville, Alabama and 19 others

RecruitingSacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of…NCT06393374·Mobile, Alabama and 310 others

CompletedA Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)This study evaluated the effect of inhaled aclidinium bromide on exercise endurance and in reducing resting and dynamic lung hyperinflation in patients with moderate to severe…NCT00500318·Jasper, Alabama and 51 others

RecruitingA Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsThis is a Phase 1a/1b, open-label, dose escalation and expansion study to evaluate the safety and efficacy of CTIM-76 (study drug), a CLDN6-directed T cell-engaging bispecific…NCT06515613·Little Rock, Arkansas and 14 others

CompletedTo Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp PsoriasisThis is a phase III, randomized, double-blind, placebo-controlled, parallel- group, multiple-site study to evaluate the therapeutic equivalence of generic calcipotriene and…NCT03331523·Encinitas, California and 30 others

Active not recruitingAn Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström MacroglobulinemiaThe purpose of this study is to evaluate the safety, pharmacokinetics, pharmacodynamics, and activity of acalabrutinib in treating subjects with WM.NCT02180724·Santa Barbara, California and 37 others

CompletedPhase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck CancerThis is a randomized, open-label, multi-center, 3-arm, global Phase III study to determine the efficacy and safety of MEDI4736 + tremelimumab combination or MEDI4736 monotherapy…NCT02551159·Aurora, Colorado and 196 others

CompletedBiomarker and DNA Collection in Subjects Participating in Protocol 22003The subjects that meet the inclusion and exclusion criteria and consent to participate in protocol 22003 will be offered participation in 22003A which will evaluate secreted…NCT00892580·Phoenix, Arizona and 7 others

CompletedLong-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's LymphomaRATIONALE: Assessing the long-term effects of cancer treatment in cancer survivors may help improve the ability to plan effective treatment and follow-up care.NCT00091091·Palo Alto, California and 14 others

RecruitingA Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTThis phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable…NCT04322318·Birmingham, Alabama and 204 others

CompletedA Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal CanalThis is a single arm Phase 2 study.NCT02399813·Duarte, California and 9 others

Active not recruitingStudy of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerThe purpose of this trial is to inform the future clinical development of the two investigational agents in ER+ breast cancer, LEE011 (CDK4/6 inhibitor) and BYL719 (PI3K-alpha…NCT01872260·San Diego, California and 24 others

CompletedEvaluation of Dosing Interval of Higher Doses of RanibizumabEvaluation of Dosing Interval of Higher Doses of Ranibizumab for patients with wet age-related macular degeneration (AMD).NCT00533520·Nashville, Tennessee

TerminatedStudy of Immunotherapy (Sasanlimab) in Combination With Targeted Therapies in People With Advanced Non-small Cell Lung Cancer (NSCLC) (Landscape 1011 Study)Phase 1b/Phase 2 Umbrella Study; open-label, multi-center, parallel group study.NCT04585815·Duarte, California and 54 others

PreviousPage 97 of 541Next

Diabetes

in Nashville

Heart Diseasein Nashville